![]() |
市場調查報告書
商品編碼
2160837
發酵衍生蛋白市場預測至2034年-按蛋白質類型、發酵類型、技術、原料、應用和地區分類的全球分析Fermentation-Derived Protein Market Forecasts to 2034 - Global Analysis By Protein Type, Fermentation Type, Technology, Source, Application, and Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球發酵衍生蛋白市場規模將達到 12 億美元,並在預測期內以 34.1% 的複合年成長率成長,到 2034 年將達到 125 億美元。
發酵蛋白是指利用真菌、酵母、細菌或其他基因改造微生物等微生物進行微生物發酵而生產的蛋白質。可控發酵系統能夠生產具有特定營養、功能和感官特性的蛋白質原料,用於食品和飲料產業。其應用包括乳製品替代品、肉類替代品、運動營養產品、蛋白飲料、烘焙產品和機能性食品。發酵技術能夠實現穩定的生產,並可高效生產傳統農業難以取得的蛋白質。市場需求主要受替代蛋白的開發、食品系統的永續性、蛋白質多樣化以及工業生物技術進步的驅動。生產創新主要集中在微生物菌株的改良、發酵效率的提高、原料的最佳化、下游分離以及可擴展的生物製程等方面。微發酵可以生產具有特定功能特性的特定蛋白質,而生質能發酵則可以生產更廣泛的富含蛋白質的原料。目前的研究進展旨在降低生產成本、改善風味、提高蛋白質產量並增強配方的多樣性。
市場動態
對永續蛋白質來源的需求日益成長
人口成長和肉類消費量的增加推動了全球蛋白質需求的成長,給傳統蛋白質供應帶來壓力,並促使人們對發酵蛋白產生興趣。人們對畜牧業環境影響的日益關注也促進了發酵蛋白的普及。發酵技術能夠有效率且環保地生產蛋白質。對發酵技術投資的增加正在加速其商業化進程。消費者對替代蛋白的興趣也推動了市場擴張。
高昂的生產成本和監管挑戰
發酵蛋白的高生產成本使其難以與傳統蛋白展開價格競爭。從實驗室規模化生產到商業化生產的挑戰也影響生產的經濟效益。新食品配料的法規核准流程因地區而異,耗時較長。有限的生產能力限制了產品開發和商業用途的供應。消費者對發酵蛋白的接受度可能取決於其對加工方法的認知。
精準發酵和菌株開發的進展
精準發酵技術的進步使得生產高純度、均一的功能性蛋白質成為可能。改良微生物菌株的開發提高了蛋白質的產量和功能性。發酵產能的加大投入正加速商業化進程。發酵衍生蛋白質新應用的開發正在創造市場機會。原料生產商和食品生產商之間的合作正在拓展其潛在用途。
植物來源蛋白質與傳統蛋白質之間的競爭
來自植物來源蛋白質和傳統動物性蛋白質的競爭可能會限制發酵蛋白的普及。經濟壓力可能會影響對發酵設施的投資。影響新食品核准的監管變化可能會影響市場發展。消費者對發酵蛋白的懷疑態度可能會影響其普及化。發酵蛋白的快速成長將吸引新的參與企業,並加劇競爭。
新冠感染疾病凸顯了傳統蛋白質供應鏈的脆弱性,並加速了人們對發酵衍生蛋白的興趣。消費者對永續性和食品系統韌性的日益關注正在推動市場擴張。疫情後,對發酵技術的投資增加,帶動了對發酵衍生蛋白的需求。人們對發酵潛力的認知不斷提高,也持續促進市場發展。
在預測期內,菌蛋白細分市場預計將佔據最大的市場佔有率。
菌蛋白是商業性程度最高的發酵衍生蛋白,具有充足的產能和消費者認可度,因此預計在預測期內將佔據最大的市場佔有率。肉類替代品對菌蛋白日益成長的需求正在推動市場擴張。菌蛋白生產技術的進步提高了效率並降低了成本。完善的供應基礎設施和應用專業知識鞏固了該領域的領先地位。
在預測期內,精準發酵領域預計將呈現最高的複合年成長率。
在預測期內,微發酵領域預計將呈現最高的成長率,這主要得益於微發酵技術在特定功能蛋白生產中的應用日益廣泛。微發酵能夠生產出與乳製品或雞蛋中蛋白質品質相當的蛋白質。對微發酵生產能力的投資增加正在加速市場擴大。微發酵是發酵衍生蛋白領域中成長最快的細分市場。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於該地區強大的發酵蛋白企業網路和先進的生物技術基礎設施。美國擁有許多具備成熟生產能力的大型企業。對食品技術投資的不斷成長正在鞏固該地區的市場領先地位。消費者日益增強的永續性意識也推動了市場擴張。
在預測期內,歐洲地區預計將呈現最高的複合年成長率,這主要得益於對永續食品創新強力的監管支持以及消費者意識的不斷提高。歐盟政策正在支持替代蛋白的開發。大量的研究經費和企業投資正在推動這些技術的商業化。對永續性的高度重視正在推動全部區域發酵衍生蛋白的採用。
According to Stratistics MRC, the Global Fermentation-Derived Protein Market is accounted for $1.2 billion in 2026 and is expected to reach $12.5 billion by 2034 growing at a CAGR of 34.1% during the forecast period. Fermentation-Derived Protein comprises proteins produced through microbial fermentation using organisms such as fungi, yeast, bacteria, or other engineered microorganisms. Controlled fermentation systems can generate protein ingredients with targeted nutritional, functional, and sensory characteristics for use in food and beverage products. Applications include alternative dairy, meat alternatives, sports nutrition, protein beverages, bakery products, and functional foods. Fermentation can provide consistent production and enable the manufacture of proteins that may be difficult to obtain efficiently through conventional agriculture. Demand is driven by alternative protein development, food-system sustainability, protein diversification, and advances in industrial biotechnology. Production innovation focuses on microbial strain engineering, fermentation efficiency, feedstock optimization, downstream separation, and scalable bioprocessing. Precision fermentation can also produce specific proteins with defined functional properties, while biomass fermentation can generate broader protein-rich ingredients. Ongoing development targets lower production costs, improved flavor, higher protein yields, and greater formulation versatility.
Market Dynamics
Growing demand for sustainable protein sources
Increasing global demand for protein, driven by population growth and rising meat consumption, is creating pressure on conventional protein supply and driving interest in fermentation-derived proteins. Growing awareness of the environmental impact of animal agriculture supports adoption of fermentation-derived proteins. Fermentation enables production of proteins with high efficiency and low environmental footprint. Growing investment in fermentation technology accelerates commercialization. Consumer interest in alternative proteins supports market expansion.
High production costs and regulatory challenges
High production costs for fermentation-derived proteins present barriers to price competitiveness with conventional proteins. Scale-up challenges from laboratory to commercial production affect production economics. Regulatory approval processes for novel food ingredients vary across regions and can be lengthy. Limited production capacity constrains supply availability for product development and commercial applications. Consumer acceptance of fermentation-derived proteins may be affected by perceptions of processing.
Advances in precision fermentation and strain development
Advances in precision fermentation enable production of specific functional proteins with high purity and consistency. Development of improved microbial strains enhances protein yield and functionality. Growing investment in fermentation capacity accelerates commercialization. Expansion of fermentation-derived proteins into new applications creates market opportunities. Partnerships between ingredient companies and food manufacturers expand application possibilities.
Competition from plant-based and conventional proteins
Competition from plant-based proteins and conventional animal-derived proteins may limit fermentation-derived protein adoption. Economic pressures may affect investment in fermentation capacity. Regulatory changes affecting novel food approval may impact market development. Consumer skepticism regarding fermentation-derived proteins may affect adoption. Rapid growth of fermentation-derived proteins attracts new entrants and intensifies competition.
The COVID-19 pandemic highlighted vulnerabilities in conventional protein supply chains, accelerating interest in fermentation-derived proteins. Growing consumer focus on sustainability and food system resilience supports market expansion. The post-pandemic period has witnessed increased investment in fermentation technology, driving demand for fermentation-derived proteins. Growing recognition of fermentation's potential continues driving market development.
The mycoprotein segment is expected to be the largest during the forecast period
The mycoprotein segment is expected to account for the largest market share during the forecast period as mycoprotein represents the most commercially established fermentation-derived protein with significant production capacity and consumer acceptance. Growing demand for mycoprotein in meat alternatives drives market expansion. Advances in mycoprotein production improve efficiency and reduce costs. Established supply infrastructure and application knowledge support segment leadership.
The precision fermentation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the precision fermentation segment is predicted to witness the highest growth rate driven by increasing adoption of precision fermentation for producing specific functional proteins. Precision fermentation enables production of dairy-identical and egg-identical proteins. Growing investment in precision fermentation capacity accelerates market expansion. Precision fermentation represents the fastest-growing segment within fermentation-derived proteins.
During the forecast period, the North America region is expected to hold the largest market share owing to strong presence of fermentation-derived protein companies and advanced biotechnology infrastructure. The United States hosts major companies with established production capabilities. Growing investment in food technology reinforces regional market leadership. High consumer awareness of sustainability supports market expansion.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR driven by strong regulatory support for sustainable food innovation and growing consumer awareness. European Union policies support alternative protein development. Significant research funding and corporate investment support technology commercialization. Strong sustainability culture drives adoption of fermentation-derived proteins across the region.
Key players in the market
Some of the key players in the Fermentation-Derived Protein Market include Perfect Day, Inc., Geltor, Inc., The EVERY Company, Motif FoodWorks, Inc., MycoTechnology, Inc., Quorn Foods, ENOUGH, Nature's Fynd, Infinite Roots, Mycorena, Imagindairy Ltd., Remilk Ltd., Formo Bio GmbH, Liberation Labs, and Helaina, Inc.
In September 2026, Perfect Day, Inc. launched a new generation of precision-fermented dairy proteins with enhanced functional properties for cheese and yogurt applications. The proteins offer improved melt, stretch, and texture characteristics. This development addresses growing demand for precision-fermented ingredients.
In June 2026, The EVERY Company introduced a new precision-fermented egg protein for use in bakery and confectionery applications. The protein offers functionality comparable to conventional egg whites. This launch addresses growing demand for animal-free egg proteins.
In March 2026, Motif FoodWorks, Inc. announced the launch of a new fermentation-derived protein that improves the texture and taste of plant-based meat alternatives. The protein enables plant-based products to exhibit more meat-like texture. This development addresses a key technical challenge limiting consumer acceptance.
In December 2025, Nature's Fynd announced the commercial launch of its fermentation-derived protein for meat alternative applications following successful regulatory approval. The ingredient offers high protein content and meat-like texture. This launch represents a major milestone in fermentation-derived protein commercialization.
In August 2025, Quorn Foods expanded its fermentation-derived protein portfolio with new products for food manufacturers. The products offer consistent quality and functionality for diverse applications. This expansion addresses growing demand for fermentation-derived proteins.
In April 2025, MycoTechnology, Inc. launched a new range of fermentation-derived proteins for dairy alternative applications. The products offer improved taste and texture compared to earlier generations. This launch addresses growing demand for fermentation-derived proteins.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.